← SynDRA
SARCOSINE
SynDRA canonical compound SYN0002957 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SLC6A9 |
|---|
| Mechanism of action | Glycine transporter inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Glycine transporter inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Methylamino-acetic acid
- N-methylglycine
- Sarcosinic acid
- Methylglycine
- Glycine, N-methyl-
- Methylaminoacetic acid
- 2-(methylamino)acetic acid
- N-Methylaminoacetic acid
- Sarcosin
- (Methylamino)acetic acid
- (Methylamino)ethanoic acid
- Sargosine hydrochloride
- N-methyl-Glycine
- Acetic acid, (methylamino)-
- Cocoylsarcosine
- Polysarcosine
- H-Sar-OH
- UNII-Z711V88R5F
- BRN 1699442
- Sarcosine, 98%
- AI3-15410
- Methylamino-Acetic Acid
- EINECS 203-538-6
- SAR
- CHEMBL304383
- CHEBI:15611
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N
- Z711V88R5F
- N Methylglycine
- (methylamino)acetate
- Methylaminoethanoic acid
- Sarcosylate, Magnesium
- METHYL GLYCOCOLL
- RefChem:181358
- DTXCID9027025
- 2-(methylazaniumyl)acetate
- N-Methylglycocoll
- MFCD00004279
Look up SARCOSINE in the interactive SynDRA portal →